Abstract
Background The Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score is a recognized tool for dementia risk stratification. However, its application is limited due to the requirements for multidimensional information and fasting blood draw. Consequently, effective, and noninvasive tool for screening individuals with high dementia risk in large population-based settings is urgently needed.
Methods A deep learning algorithm based on fundus photographs for estimating the CAIDE dementia risk score was developed and internally validated by a medical check-up dataset included 271,864 participants, and externally validated by two independent datasets, one included 19,178 medical check-up participants, another included 1,512 community residents. The performance for identifying individuals with high dementia risk (CAIDE score ≥10 points) was evaluated by area under the receiver operating curve (AUC) with 95% confidence interval (CI).
Findings The algorithm achieved an AUC of 0·944 (95% CI, 0·939–0·950) in the internal validation, 0·877 (95% CI, 0.847–0.907) and 0·781 (95% CI, 0·748–0·814) in the external validations, respectively. Besides, the estimated CAIDE score was significantly associated with both comprehensive cognitive function and specific cognitive domains.
Interpretation This algorithm trained via fundus photographs could well identify individuals with high dementia risk in a population setting. Therefore, it has potential to be utilized as a noninvasive and more expedient method for dementia risk stratification.
Funding We were supported by National Natural Science Foundation of China (project no. 81974489), 2019 Irma and Paul Milstein Program for Senior Health Research Project Award, National Key R&D Programme of China (2017YFE0118800).
Evidence before this study The retina is an exceptional site where the microcirculation can be handily and noninvasively visualized by fundus photography, thus providing insights into the brain microvasculature. The emerging artificial intelligence technique might be a promising tool to integrate multiple retinal features for identifying individuals with high dementia risk. We searched PubMed up to Feb 24, 2022 with no language restrictions, by the search terms: (“retina” or “fundus”) and (“deep learning” or “artificial intelligence” or “AI”) and (“dementia” or “Alzheimer’s disease” or “CAIDE”), 15 records were yielded. However, we did not find any artificial intelligence algorithm trained by retinal images for estimating or predicting dementia risk.
Added value of this study To the best of our knowledge, the present study is the first investigation on developing a deep learning algorithm based on fundus photographs for identifying individuals with high dementia risk. The algorithm developed by fundus photographs from 258,305 check-up participants could well identify individuals with high dementia risk, with an AUC of 0·944 in internal validation, 0·877 and 0·781 in two independent external validation datasets, respectively. Besides, the estimated CAIDE dementia risk score exhibited significant association with cognitive function. These findings suggested that the deep learning algorithm based on fundus photographs has potential to identify individuals with high dementia risk in population-based settings. Previous studies have investigated deep learning algorithm based on fundus photographs for predicting cardiovascular diseases, our study added novel evidence regarding dementia in this field, potentially facilitating the eventual application of fundus photography for simultaneous screening of multiple diseases in large population-based settings.
Implications of all the available evidence This work indicated that a deep learning algorithm trained via fundus photographs could well identify individuals with high dementia risk. Therefore, it has potential application in community-based screening or clinic, and could also be adopted in dementia clinical trials, incorporated as inclusion criteria to efficiently select eligible participants. Future research on escalating the artificial intelligence technology, as well as collecting larger and more detailed datasets, are warranted to further improve and verify the algorithm’s performance.
Competing Interest Statement
Jianhao Xiong, Zongyuan Ge, Meng Fu, Bin Wang, Xin Zhao, Chao He, and Yuzhong Chen are employees of Beijing Eaglevision Technology Development Co., Ltd. All other authors declare no competing interests.
Funding Statement
We were supported by National Natural Science Foundation of China (project no. 81974489), 2019 Irma and Paul Milstein Program for Senior Health Research Project Award, National Key R&D Programme of China (2017YFE0118800).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of the dataset for the algorithm training was approved by Tongren Hospital Institutional Review Board, Shibei Hospital Institutional Review Board, and iKang Healthcare Group Institutional Review Board with a waiver of informed consent. The use of the HMI dataset was approved by Chinese PLA General Hospital Institutional Review Board (ethical review approval number: S2019-131-01), all participants provided written informed consent. Another external validation dataset (BRAVE) was approved by the Peking University School Institutional Review Board (ethical review approval number: IRB0001052-19060), all participants have given written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Individual participant data will be made available upon reasonable request, directed to the corresponding author (WX and QZ). Data can be shared through a secure online platform for research purposes. We applied the open-source machine-learning framework InceptionResNetV2 to do the experiments. Considering that many aspects of the experimental system (like data generation and model training) largely depend on our internal infrastructure, tooling, and hardware, we are unable to publicly release the code in the present stage. However, the experiments and implementation approaches are provided in the methods section.
